Current Opinion in Pharmacology

1

The antimalarial pipeline

Hooft van Huijsduijnen, Rob, Wells, Timothy NC

Journal:

Year:

2018

Language:

english

File:

PDF, 283 KB

english, 2018

2

Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

Koch, Anastasia, Cox, Helen, Mizrahi, Valerie

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 648 KB

english, 2018

3

Advanced cellular systems to study tuberculosis treatment

Bielecka, Magdalena K, Elkington, Paul

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 1.34 MB

english, 2018

4

Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis

Lee, Bei Shi, Pethe, Kevin

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 300 KB

english, 2018

5

Predicting how drug molecules bind to their protein targets

Rachman, Moira M, Barril, Xavier, Hubbard, Roderick E

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 626 KB

english, 2018

6

Filling the drug discovery gap: is high-content screening the missing link?

Dorval, Thierry, Chanrion, Benjamin, Cattin, Marie-Elodie, Stephan, Jean Philippe

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 512 KB

english, 2018

7

Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite

Martin, Rowena E, Shafik, Sarah H, Richards, Sashika N

Journal:

Current Opinion in Pharmacology

Year:

2018

File:

PDF, 1.02 MB

2018

8

The present state of the tuberculosis drug development pipeline

J Libardo, M Daben, Boshoff, Helena IM, Barry, Clifton E

Journal:

Current Opinion in Pharmacology

Year:

2018

File:

PDF, 2.08 MB

2018

9

Mechanisms of artemisinin resistance in Plasmodium falciparum malaria

Suresh, Niraja, Haldar, Kasturi

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 1.61 MB

english, 2018

10

Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads

Panic, Gordana, Keiser, Jennifer

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 498 KB

english, 2018

11

Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?

Bruyneel, Arne AN, McKeithan, Wesley L, Feyen, Dries AM, Mercola, Mark

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 452 KB

english, 2018

12

How scientific literature analysis yields innovative therapeutic hypothesis through integrative iterations

Iris, Francois, Beopoulos, Athanasios, Gea, Manuel

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 599 KB

english, 2018

13

Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite

Martin, Rowena E, Shafik, Sarah H, Richards, Sashika N

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 1.02 MB

english, 2018

14

The present state of the tuberculosis drug development pipeline

J Libardo, M Daben, Boshoff, Helena IM, Barry, Clifton E

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 2.08 MB

english, 2018

15

Turning omics data into therapeutic insights

Kedaigle, Amanda, Fraenkel, Ernest

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 491 KB

english, 2018

16

Recent advances in combinatorial drug screening and synergy scoring

Pemovska, Tea, Bigenzahn, Johannes W, Superti-Furga, Giulio

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 784 KB

english, 2018

17

In silico models in drug development: where we are

Piñero, Janet, Furlong, Laura I, Sanz, Ferran

Journal:

Current Opinion in Pharmacology

Year:

2018

Language:

english

File:

PDF, 489 KB

english, 2018

18

Volume 42

The antimalarial pipeline

Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment

Advanced cellular systems to study tuberculosis treatment

Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis

Predicting how drug molecules bind to their protein targets

Filling the drug discovery gap: is high-content screening the missing link?

Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite

The present state of the tuberculosis drug development pipeline

Mechanisms of artemisinin resistance in Plasmodium falciparum malaria

Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads

Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?

How scientific literature analysis yields innovative therapeutic hypothesis through integrative iterations

Mechanisms of resistance to the partner drugs of artemisinin in the malaria parasite

The present state of the tuberculosis drug development pipeline

Turning omics data into therapeutic insights

Recent advances in combinatorial drug screening and synergy scoring

In silico models in drug development: where we are

Contents